Detection and Characterization of Musculoskeletal Cancer Using Whole-Body Magnetic Resonance Imaging.


Journal

Seminars in musculoskeletal radiology
ISSN: 1098-898X
Titre abrégé: Semin Musculoskelet Radiol
Pays: United States
ID NLM: 9717520

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 11 12 2020
pubmed: 12 12 2020
medline: 5 8 2021
Statut: ppublish

Résumé

Whole-body magnetic resonance imaging (WB-MRI) is gradually being integrated into clinical pathways for the detection, characterization, and staging of malignant tumors including those arising in the musculoskeletal (MSK) system. Although further developments and research are needed, it is now recognized that WB-MRI enables reliable, sensitive, and specific detection and quantification of disease burden, with clinical applications for a variety of disease types and a particular application for skeletal involvement. Advances in imaging techniques now allow the reliable incorporation of WB-MRI into clinical pathways, and guidelines recommending its use are emerging. This review assesses the benefits, clinical applications, limitations, and future capabilities of WB-MRI in the context of other next-generation imaging modalities, as a qualitative and quantitative tool for the detection and characterization of skeletal and soft tissue MSK malignancies.

Identifiants

pubmed: 33307587
doi: 10.1055/s-0040-1719018
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

726-750

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Amanda Isaac (A)

School of Biomedical Engineering & Imaging Sciences, Kings College London, United Kingdom.
Guy's & St Thomas' Hospitals, London, United Kingdom.

Frederic Lecouvet (F)

Department of Radiology, Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

Danoob Dalili (D)

School of Biomedical Engineering & Imaging Sciences, Kings College London, United Kingdom.
Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Laura Fayad (L)

The Russell H. Morgan Department of Radiology and Radiological Science, John's Hopkins School of Medicine, Baltimore, Maryland.

Vasiliki Pasoglou (V)

Department of Radiology, Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

Olympia Papakonstantinou (O)

2nd Department of Radiology, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

Shivani Ahlawat (S)

The Russell H. Morgan Department of Radiology and Radiological Science, John's Hopkins School of Medicine, Baltimore, Maryland.

Christina Messiou (C)

The Royal Marsden Hospital, London, United Kingdom.
The Institute of Cancer Research, London, United Kingdom.

Marc-André Weber (MA)

Institute of Diagnostic and Interventional Radiology, Paediatric Radiology and Neuroradiology, University Medical Centre Rostock, Rostock, Germany.

Anwar R Padhani (AR)

The Institute of Cancer Research, London, United Kingdom.
Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH